UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Phytotherapy research, ISSN 0951-418X, 12/2018, Volume 32, Issue 12, pp. 2577 - 2585
tincture | botanical | antibiotic resistance | Staphylococcus aureus | MRSA | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Arctostaphylos - chemistry | Staphylococcal Infections - drug therapy | Plant Extracts - pharmacology | Humans | Methicillin - therapeutic use | Methicillin-Resistant Staphylococcus aureus - drug effects | Plant Extracts - isolation & purification | Anti-Bacterial Agents - isolation & purification | Eucalyptus - chemistry | Microbial Sensitivity Tests | Methicillin-Resistant Staphylococcus aureus - growth & development | Larrea - chemistry | Anti-Bacterial Agents - pharmacology | Staphylococcal Infections - microbiology | Phytotherapy | Staphylococcus aureus - drug effects | Staphylococcus aureus - growth & development | Hypericum - chemistry | Drug resistance in microorganisms | Usage | Health aspects | Analysis | Staphylococcus aureus infections | Methicillin | Antibiotics | Multidrug resistance | Antibiotic resistance | Penicillin | Minimum inhibitory concentration | Opportunist infection | Staphylococcus infections | Drug resistance | Index Medicus
Journal Article
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, ISSN 1341-321X, 2015, Volume 22, Issue 1, pp. 1 - 13
Hematology, Oncology and Palliative Medicine | Infection | Anaerobes | Antimicrobial resistance | Antibiotics | Bacteroides fragilis | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Science & Technology | Cefoxitin - therapeutic use | Penicillins - therapeutic use | Bacterial Infections - drug therapy | Humans | Minocycline - analogs & derivatives | Anti-Infective Agents - therapeutic use | Drug Resistance, Bacterial | Chloramphenicol - therapeutic use | Bacteria, Anaerobic - pathogenicity | Clindamycin - therapeutic use | Carbapenems - therapeutic use | Metronidazole - therapeutic use | Minocycline - therapeutic use | beta-Lactamase Inhibitors - therapeutic use | Bacterial Infections - microbiology | Bacteria, Anaerobic - growth & development | Index Medicus
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 12/2016, Volume 22, Issue 12, pp. 1005.e1 - 1005.e7
Biotype | Toxin | Antimicrobial susceptibility | Algeria | MLST | Corynebacterium diphtheriae | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Cefotaxime - therapeutic use | Penicillin G - therapeutic use | Diphtheria - drug therapy | Algeria - epidemiology | Humans | Middle Aged | Male | Phylogeny | Genotyping Techniques | Multilocus Sequence Typing | Microbial Sensitivity Tests | Young Adult | Anti-Bacterial Agents - therapeutic use | Corynebacterium diphtheriae - genetics | Adult | Female | Rhinitis, Atrophic - drug therapy | Gentamicins - therapeutic use | Corynebacterium diphtheriae - drug effects | Tetracycline - therapeutic use | Chloramphenicol - therapeutic use | Rhinitis, Atrophic - epidemiology | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Erythromycin - therapeutic use | Corynebacterium diphtheriae - isolation & purification | Molecular Epidemiology | Vancomycin - therapeutic use | Diphtheria - epidemiology | Drug Resistance, Multiple, Bacterial - genetics | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 12/2009, Volume 49, Issue 11, pp. 1703 - 1710
Chronic granulomatous disease | Infectious diseases | Actinomycosis | Abscesses | Penicillin | Actinomyces | Infections | Fungal infections | ARTICLES AND COMMENTARIES | Lesions | Lymph nodes | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Hematologic and hematopoietic diseases | Other diseases. Hematologic involvement in other diseases | Immunopathology | Biological and medical sciences | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Communicable Diseases, Emerging - pathology | Penicillin G - therapeutic use | Humans | Male | Actinomycosis - drug therapy | Penicillin V - therapeutic use | Young Adult | Anti-Bacterial Agents - therapeutic use | Actinomyces - genetics | Granulomatous Disease, Chronic - microbiology | Bone Marrow Transplantation | Polymerase Chain Reaction | Sulfamethoxazole - therapeutic use | Adult | Female | Child | DNA, Ribosomal - genetics | Thienamycins - therapeutic use | Communicable Diseases, Emerging - microbiology | Trimethoprim - therapeutic use | Clindamycin - therapeutic use | Actinomyces - pathogenicity | Actinomycosis - diagnosis | Ceftriaxone - therapeutic use | Azithromycin - therapeutic use | Actinomycosis - surgery | Adolescent | Amoxicillin - therapeutic use | Actinomycosis - therapy | Diagnosis | Research | Risk factors | Fungi | Oxygen | Drug therapy | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 09/2016, Volume 2016, Issue 9, pp. CD004406 - CD004406
Pharyngitis/Tonsillitis (Sore throat) | Macrolides | Clindamycin | Pharynx | Randomized Controlled Trials as Topic | Tonsillitis (acute)/pharyngitis | Ear, nose, & throat | Treatment | Cephalosporins | Antibiotics | Ampicillin | Sulfonamides | Penicillins | Anti‐Bacterial Agents | Child health | Streptococcal Infections | Streptococcus pyogenes | Pharyngitis | Medicine General & Introductory Medical Sciences | Ear, nose & throat | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 2007, Volume 67, Issue 16, pp. 2355 - 2382
Dalbavancin, antimicrobial activity | Beta lactams, therapeutic use | Ceftobiprole, antimicrobial activity | Fluoroquinolones, therapeutic use | Daptomycin, antimicrobial activity | Macrolides, therapeutic use | Antimicrobial resistance | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Pneumococcal Infections - drug therapy | Anti-Bacterial Agents - therapeutic use | Streptococcus pneumoniae - drug effects | Penicillin Resistance | Drug Resistance, Multiple, Bacterial | Humans | Fluoroquinolones - therapeutic use | Drug Therapy, Combination | Macrolides - therapeutic use | beta-Lactams - therapeutic use | Index Medicus
Journal Article
International journal of oncology, ISSN 1019-6439, 12/2019, Volume 55, Issue 6, pp. 1372 - 1384
Life Sciences & Biomedicine | Oncology | Science & Technology | Pyrazoles - therapeutic use | Class I Phosphatidylinositol 3-Kinases - genetics | Apoptosis - drug effects | Humans | Child, Preschool | Infant | Male | Receptor, Fibroblast Growth Factor, Type 3 - antagonists & inhibitors | Quinolines - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Benzamides - therapeutic use | Aminopyridines - therapeutic use | DNA Mutational Analysis | Female | Benzamides - pharmacology | Imidazoles - therapeutic use | Child | Infant, Newborn | Morpholines - therapeutic use | Phosphoinositide-3 Kinase Inhibitors - therapeutic use | Pyrazoles - pharmacology | Phosphoinositide-3 Kinase Inhibitors - pharmacology | Cell Survival - drug effects | Receptor, Fibroblast Growth Factor, Type 3 - genetics | Neuroblastoma - genetics | Morpholines - pharmacology | Imidazoles - pharmacology | Piperazines - therapeutic use | Class I Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Piperazines - pharmacology | Drug Resistance, Neoplasm - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aminopyridines - pharmacology | Neuroblastoma - drug therapy | Cell Line, Tumor | Cell Proliferation - drug effects | Quinolines - therapeutic use | Mutation
Journal Article